<p>Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.</p>

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Share Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

Sign up to save your podcasts

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

More shows like GRACEcast Radiation Oncology Audio

GRACEcast Head and Neck Cancer Audio

GRACEcast Lung Cancer Video

GRACEcast Radiation Oncology Video

GRACEcast Pancreatic Cancer Audio

GRACEcast Pancreatic Cancer Video

GRACEcast Cancer 101 Audio

GRACEcast Bladder Cancer Video

GRACEcast Head and Neck Cancer Video NEW

GRACEcast Cancer 101 Video